Search for: "GENENTECH, INC." Results 341 - 360 of 469
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
27 Sep 2009, 2:30 pm
As we noted in Genentech, Inc. v. [read post]
23 Sep 2009, 8:31 am
Genentech, Inc. 927 F.2d 1565, 1583 (Fed. [read post]
27 Jul 2009, 6:40 am
Genentech, Inc., the question of "evergreening" patents was presented as both abusing and compromising the integrity of the patent system. n36 Evergreening allows inventors to file endless continuation applications, issuing patent after patent based upon on a single original patent filing.The process of continuing and patenting and continuing and patenting can continue until the 20-year patent term is finally exhausted. [read post]
5 Jul 2009, 8:40 pm
Robert McFarlane, a partner at Townsend and Townsend and Crew LLP, and Chester Chuang, Senior Corporate Counsel at Electronics For Imaging, Inc., will review the recent Federal Circuit rulings in In re TS Tech and In re Genentech, specifically focusing on the ramifications for plaintiffs who wish to continue filing patent infringement suits in the Eastern District of Texas and for defendants who would rather have their cases decided in other jurisdictions. [read post]
28 Jun 2009, 2:11 pm by Tom Casagrande
Tex. as good as any other district for that purpose.In In re Genentech Inc. and Biogen, Inc., No. [read post]
24 May 2009, 10:58 pm
In the case IN RE GENENTECH, INC. and BIOGEN IDEC INC., the petitioners sought, and obtained, a writ of mandamus to move the patent case from ED Texas to ND California. [read post]
19 May 2009, 4:23 am
Genentech, Inc. in favor or the contrary panel decision in Atlantic Thermoplastics Co. v. [read post]
15 May 2009, 2:40 pm
On April 8, 2009 notice was sent to physicians that Genentech, Inc. voluntarily withdrew the psoriasis medication Raptiva. [read post]
12 May 2009, 2:44 am
The drug was developed by OSI Pharmaceuticals Inc. and is sold by Genentech. [read post]